APGE

Apogee Therapeutics, Inc. - Common Stock (APGE)

About Apogee Therapeutics, Inc. - Common Stock (APGE)

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.

Details

Daily high
$35.66
Daily low
$33.30
Price at open
$33.30
52 Week High
$63.50
52 Week Low
$26.20
Market cap
2.1B
Dividend yield
0.00%
Volume
813,499
Avg. volume
777,258
P/E ratio
-10.99

Apogee Therapeutics, Inc. - Common Stock News

Details

Daily high
$35.66
Daily low
$33.30
Price at open
$33.30
52 Week High
$63.50
52 Week Low
$26.20
Market cap
2.1B
Dividend yield
0.00%
Volume
813,499
Avg. volume
777,258
P/E ratio
-10.99